MIT Holding, a Los Angeles-based company operating through
its network of agents, facilitators and contractual obligations to offer
professional outpatient medical care with ambulatory infusion therapies, home
infusion services, and medical equipment delivery, this morning reported its
financial results for the 2015 second quarter, marking the company’s first
quarter of profitability.
Key points include:
• MITD’s
sales for the first six months were $851,724, an increase over sales of
$473,153 for the same period of 2014. Adjusted net income for the period was
$265,967, or $0.0027 per diluted share.
• On a GAAP
basis, MITD’s first six months of 2015 earned a gross profit of $631,725
compared to $312,240 for the comparable period of 2014.
• Receivables
increased to $286,853 as compared to $208,269 for the same period of 2014.
• The
six-month period ended June 30, 2015, produced a per share profit on 202%
increase in revenues, as compared to the same period of 2014, reflecting a 37%
increase in receivables.
• MITD is
currently in the process of completing corporate audits to become fully
compliant with the SEC by year-end 2015.
“After implementing our corporate goals on January 1, 2014,
we experienced normal growing pains and produced a profitable and solid company
in 18 months. The business plan is now firmly entrenched in the expansion
phase. In addition to organic growth goals of 20-25% per year on existing
business, we expect acquisitions and the opening of new facilities in untapped
geographic locations throughout the United States. When we cannot locate a
sound acquisition for purchase within a target market, MIT Holding has the
ability to ‘open from scratch’ facilities that will host our products and
services,” Tommy Duncan, president of MIT Holding, stated in the news release.
MIT Holding Chief Executive Officer Walter Drakeford
commented on industry challenges and the company’s unique position in the
medical market.
“We are pleased with the strong financial and operational
performance of our reorganization strategy. The first six months of profit and
growth validate our strategy and approach to our business model. The unabated
growth in the medical industry is creating headwinds, contributing to our
continued growth and profitability. The MITD concept of bringing together all
necessary services and products under one umbrella for a patient’s post-medical
event recovery is, to our knowledge, the first in the industry,” he stated.
The company also announced it will hold an upcoming
investors conference call prior to the end of third quarter September 30, 2015.
Date, time and dial-in instructions will be released two weeks prior to the
call.
For more information visit http://mitholdinginc.com/
About QualityStocks
QualityStocks
is committed to connecting subscribers with companies that have huge potential
to succeed in the short and long-term future. We offer several ways for
investors to find, evaluate, and learn more about investing in these companies.
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment